{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:22:13Z","timestamp":1773246133871,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nucmedbio.2008.02.010","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T07:39:49Z","timestamp":1209886789000},"page":"561-569","source":"Crossref","is-referenced-by-count":25,"title":["[11C]-MeJDTic: a novel radioligand for \u03ba-opioid receptor positron emission tomography imaging"],"prefix":"10.1016","volume":"35","author":[{"given":"G\u00e9raldine","family":"Poisnel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Dhilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Delamare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Perrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00e8le","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa","family":"Barr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2008.02.010_bib1","first-page":"567","article-title":"International Union of Pharmacology: XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-0102(95)00933-K","article-title":"Molecular biology of the opioid receptors: structures, functions and distributions","volume":"23","author":"Minami","year":"1995","journal-title":"Neurosci Res"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib4","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1038\/sj.bjp.0706435","article-title":"75 Years of opioid research: the exciting but vain quest for the Holy Grail","volume":"147","author":"Corbett","year":"2006","journal-title":"British J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib5","first-page":"1","article-title":"U-50,488 and the kappa receptor. Part ii","volume":"53","author":"Szmuszkovicz","year":"1999","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the k-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective k-agonist U-50,488H and attenuates morphine withdrawal","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO Journal"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(00)00099-1","article-title":"Regulations of opioid dependence by opioid receptor types","volume":"89","author":"Narita","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.104.076828","article-title":"Differential cardiovascular and renal responses produced by microinjection of the k-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus","volume":"312","author":"Gottlieb","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.STR.0000125011.93188.c6","article-title":"Prolonged opportunity for ischemic neuroprotection with selective k-opioid receptor agonist in rats","volume":"35","author":"Chen","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0091-3057(03)00218-1","article-title":"Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice","volume":"76","author":"Manocha","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib11","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1208\/aapsj070361","article-title":"k Opioids as potential treatments for stimulant dependence","volume":"7","author":"Prinsinzano","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00401-007-0269-7","article-title":"Long-term alterations in m, d and k opioidergic receptors following middle cerebral artery occlusion in mice","volume":"114","author":"Boutin","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(03)00027-0","article-title":"Salvinorin A: the \u2018magic mint\u2019 hallucinogen finds a molecular target in the kappa opioid receptor","volume":"24","author":"Sheffler","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0165-1781(93)90084-T","article-title":"Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot study","volume":"47","author":"Chappell","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(00)03302-3","article-title":"Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients","volume":"893","author":"Mathieu-Kia","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib16","first-page":"386","article-title":"Radioligands for brain imaging of the k-opioid system","volume":"46","author":"Machulla","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/1381612043452992","article-title":"PET imaging of opioid receptors in pain: progress and new directions","volume":"10","author":"Ravert","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib18","first-page":"484","article-title":"[11C]-GR103545, a radiotracer for imaging k-opioid receptors in vivo with PET : synthesis and evaluation in baboons","volume":"46","author":"Talbot","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0969-8051(01)00285-2","article-title":"[11C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers","volume":"29","author":"Ravert","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib20","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/jm00067a004","article-title":"A\u00a0potent new class of k-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines","volume":"36","author":"Naylor","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib21","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/jm0108395","volume":"44","author":"Soukara","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3565(24)29474-X","article-title":"GR89,696: a potent k-opioid agonist with subtype selectivity in rhesus monkeys","volume":"298","author":"Butelman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(00)00208-9","article-title":"5\u2032-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist","volume":"396","author":"Jones","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib25","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1021\/jm015521r","article-title":"Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid k receptor antagonist activity","volume":"44","author":"Thomas","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib26","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1021\/jm030094y","article-title":"Identification of (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid k receptor antagonist","volume":"46","author":"Thomas","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","article-title":"Pharmacological properties of JDTic: a novel k-opioid receptor antagonist","volume":"501","author":"Carroll","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2005.09.013","article-title":"Effects of JDTic, a selective k-opioid antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model","volume":"524","author":"Carroll","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib30","series-title":"Handbook of radiopharmaceuticals \u2014 Radiochemistry and applications","first-page":"141","article-title":"Aspects on the synthesis of 11C-labelled compounds","author":"Antoni","year":"2003"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib31","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1016\/j.bmc.2006.02.029","article-title":"Synthesis and biodistribution of [11C]R107474, a new radiolabeled a2-adrenoceptor antagonist","volume":"14","author":"Van der Mey","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0883-2889(87)90123-7","article-title":"Recommendations for a practical production of [11C]-methyl iodide","volume":"38","author":"Crouzel","year":"1987","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0883-2889(92)90012-4","article-title":"A simple synthesis of [11C]-methyl triflate","volume":"43","author":"Jewett","year":"1992","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(97)00988-8","article-title":"Quantitative autoradiographic mapping of \u00b5-, d- and k-opioid receptors in knockout mice lacking the \u00b5-opioid receptor gene","volume":"778","author":"Kitchen","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib35","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0024-3205(00)00434-3","article-title":"Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea","volume":"66","author":"Zebraski","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","article-title":"Determination of lipophilicity and its use as a predictor of blood\u2013brain barrier penetration of molecular imaging agents","volume":"5","author":"Waterhouse","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","article-title":"Determination of lipophilicity and its use as a predictor of blood brain barrier penetration of molecular imaging agents","volume":"5","author":"Waterhouse","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib38","series-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/mcne.1994.1039","article-title":"Distribution of k-opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study","volume":"5","author":"DePaoli","year":"1994","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nucmedbio.2008.02.010_bib40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0024-3205(92)90138-F","article-title":"Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone","volume":"50","author":"Takemori","year":"1992","journal-title":"Life Sci"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:39:27Z","timestamp":1738201167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805108000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0969805108000620"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2008.02.010","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}